(2R,6R)-2-[(E)-(2S,6S,10S,11S)-10,11-Bis-(tert-butyl-dimethyl-silanyloxy)-6-methoxymethoxy-2-methyl-4-methylene-trideca-7,12-dienyl]-6-(3-trimethylsilanyl-prop-2-ynyl)-3,6-dihydro-2H-pyran | 911834-95-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡喃
• 英文名称: (2R,6R)-2-[(E)-(2S,6S,10S,11S)-10,11-Bis-(tert-butyl-dimethyl-silanyloxy)-6-methoxymethoxy-2-methyl-4-methylene-trideca-7,12-dienyl]-6-(3-trimethylsilanyl-prop-2-ynyl)-3,6-dihydro-2H-pyran
• 英文别名: 3-[(2R,6R)-2-[(2S,6S,7E,10S,11S)-10,11-bis[[tert-butyl(dimethyl)silyl]oxy]-6-(methoxymethoxy)-2-methyl-4-methylidenetrideca-7,12-dienyl]-3,6-dihydro-2H-pyran-6-yl]prop-1-ynyl-trimethylsilane
• CAS: 911834-95-2
• 化学式: C₄₀H₇₄O₅Si₃
• 分子量: 719.281
• InChiKey: OPUIXTQMVGTYDK-ZTRYMXPJSA-N

物化性质

• 沸点：
  636.4±55.0 °C(Predicted)
• 密度：
  0.923±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  11.24
• 重原子数：
  48
• 可旋转键数：
  22
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  46.2
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (2R,6R)-2-[(E)-(2S,6S,10S,11S)-10,11-Bis-(tert-butyl-dimethyl-silanyloxy)-6-methoxymethoxy-2-methyl-4-methylene-trideca-7,12-dienyl]-6-(3-trimethylsilanyl-prop-2-ynyl)-3,6-dihydro-2H-pyran 在 正丁基锂 、 四丁基氟化铵 作用下， 以 四氢呋喃 为溶剂， 反应 3.29h， 生成 4-[(2R,6R)-6-((E)-(2S,6S,10S,11S)-10,11-Dihydroxy-6-methoxymethoxy-2-methyl-4-methylene-trideca-7,12-dienyl)-5,6-dihydro-2H-pyran-2-yl]-but-2-ynoic acid
  参考文献：
  名称：

  Pharmacophore Mapping in the Laulimalide Series:  Total Synthesis of a Vinylogue for a Late-Stage Metathesis Diversification Strategy

  摘要：

  An efficient synthesis of the macrocyclic core of laulimalide with a pendant vinyl group at C20 is described, allowing for late-stage introduction of various side chains through a selective and efficient cross metathesis diversification step. Representative analogues reported herein are the first to contain modifications to only the side chain dihydropyran of laulimalide and des-epoxy laulimalide. This step-economical strategy enables the rapid synthesis of new analogues using alkenes as an inexpensive, abundantly available diversification feedstock.

  DOI：

  10.1021/ol061619u
• 作为产物：
  描述：

  1-(三甲基硅基)丙炔 在 四(三苯基膦)钯 、 正丁基锂 、 cerium(III) chloride 、 四甲基乙二胺 、 D-tartaric acid derivative 、 三正丁基氢锡 、 silica gel 、 N,N-二异丙基乙胺 、 lithium chloride 作用下， 以 四氢呋喃 、 乙醚 、 正己烷 、 二氯甲烷 为溶剂， 反应 124.58h， 生成 (2R,6R)-2-[(E)-(2S,6S,10S,11S)-10,11-Bis-(tert-butyl-dimethyl-silanyloxy)-6-methoxymethoxy-2-methyl-4-methylene-trideca-7,12-dienyl]-6-(3-trimethylsilanyl-prop-2-ynyl)-3,6-dihydro-2H-pyran
  参考文献：
  名称：

  Pharmacophore Mapping in the Laulimalide Series:  Total Synthesis of a Vinylogue for a Late-Stage Metathesis Diversification Strategy

  摘要：

  An efficient synthesis of the macrocyclic core of laulimalide with a pendant vinyl group at C20 is described, allowing for late-stage introduction of various side chains through a selective and efficient cross metathesis diversification step. Representative analogues reported herein are the first to contain modifications to only the side chain dihydropyran of laulimalide and des-epoxy laulimalide. This step-economical strategy enables the rapid synthesis of new analogues using alkenes as an inexpensive, abundantly available diversification feedstock.

  DOI：

  10.1021/ol061619u

文献信息

• LAULIMALIDE AND LAULIMALIDE ANALOGS
  申请人：WENDER PAUL A.

  公开号：US20080227851A1

  公开（公告）日：2008-09-18

  Novel laulimalide analogs, methods for the treatment of proliferative disease and processes for the synthesis of laulimalide and novel laulimalide analogs are described.

  描述了新型laulimalide类似物、治疗增殖性疾病的方法以及合成laulimalide和新型laulimalide类似物的过程。
• Pharmacophore Mapping in the Laulimalide Series:  Total Synthesis of a Vinylogue for a Late-Stage Metathesis Diversification Strategy
  作者：Paul A. Wender、Michael K. Hilinski、Philip R. Skaanderup、Nicolas G. Soldermann、Susan L. Mooberry

  DOI：10.1021/ol061619u

  日期：2006.8.1

  An efficient synthesis of the macrocyclic core of laulimalide with a pendant vinyl group at C20 is described, allowing for late-stage introduction of various side chains through a selective and efficient cross metathesis diversification step. Representative analogues reported herein are the first to contain modifications to only the side chain dihydropyran of laulimalide and des-epoxy laulimalide. This step-economical strategy enables the rapid synthesis of new analogues using alkenes as an inexpensive, abundantly available diversification feedstock.